{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:35:49Z","timestamp":1792431349855,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Danish Council for Independent Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005747","name":"AP M\u00f8ller and Chastine McKinney M\u00f8ller Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009908","name":"Wholesaler L F Foght Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009908","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.clinph.2021.09.012","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T15:26:13Z","timestamp":1634138773000},"page":"3125-3135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The role of potassium in muscle membrane dysfunction in end-stage renal disease"],"prefix":"10.1016","volume":"132","author":[{"given":"Lotte Hardbo","family":"Larsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner J.","family":"Z'Graggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Bostock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Veronica","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels Henrik","family":"Buus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice","family":"Tankisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clinph.2021.09.012_b0005","doi-asserted-by":"crossref","first-page":"e0171597","DOI":"10.1371\/journal.pone.0171597","article-title":"The sensitivity and specificity of the neurological examination in polyneuropathy patients with clinical and electrophysiological correlations","volume":"12","author":"Abraham","year":"2017","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.clinph.2021.09.012_b0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ekir.2017.10.001","article-title":"Treatment of severe hyperkalemia: confronting 4 fallacies","volume":"3","author":"Abuelo","year":"2018","journal-title":"Kidney Int Rep"},{"issue":"4","key":"10.1016\/j.clinph.2021.09.012_b0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/01.nrl.0000263699.53969.e9","article-title":"Neuromuscular complications in uremics: a review","volume":"13","author":"Al-Hayk","year":"2007","journal-title":"Neurologist"},{"issue":"10","key":"10.1016\/j.clinph.2021.09.012_b0020","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.2215\/CJN.00670117","article-title":"Randomized, controlled trial of the effect of dietary potassium restriction on nerve function in CKD","volume":"12","author":"Arnold","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.clinph.2021.09.012_b0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.clinph.2013.06.022","article-title":"Evidence for a causal relationship between hyperkalaemia and axonal dysfunction in end-stage kidney disease","volume":"125","author":"Arnold","year":"2014","journal-title":"Clin Neurophysiol"},{"issue":"1","key":"10.1016\/j.clinph.2021.09.012_b0030","first-page":"187","article-title":"The negative after potential of human muscle fibres","volume":"79","author":"Bergmans","year":"1971","journal-title":"Arch Int Physiol Biochim"},{"issue":"1","key":"10.1016\/j.clinph.2021.09.012_b0035","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/mus.23267","article-title":"Muscle velocity recovery cycles: effects of repetitive stimulation on two muscles","volume":"46","author":"Boerio","year":"2012","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.clinph.2021.09.012_b0040","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/mus.23429","article-title":"Temperature dependency of human muscle velocity recovery cycles","volume":"46","author":"Bostock","year":"2012","journal-title":"Muscle Nerve"},{"issue":"17","key":"10.1016\/j.clinph.2021.09.012_b0045","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1113\/jphysiol.2008.155424","article-title":"Do multiple ionic interactions contribute to skeletal muscle fatigue?","volume":"586","author":"Cairns","year":"2008","journal-title":"J Physiol"},{"issue":"5","key":"10.1016\/j.clinph.2021.09.012_b0050","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1046\/j.1523-1755.2002.00614.x","article-title":"Uremic myopathy","volume":"62","author":"Campistol","year":"2002","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.clinph.2021.09.012_b0055","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"3","key":"10.1016\/j.clinph.2021.09.012_b0060","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1172\/JCI109328","article-title":"Resting skeletal muscle membrane potential as an index of uremic toxicity. A proposed new method to assess adequacy of hemodialysis","volume":"63","author":"Cotton","year":"1979","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.clinph.2021.09.012_b0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1172\/JCI106483","article-title":"Resting transmembrane potential difference of skeletal muscle in normal subjects and severely ill patients","volume":"50","author":"Cunningham","year":"1971","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.clinph.2021.09.012_b0070","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0272-6386(12)80430-6","article-title":"Morphologic features of the myopathy associated with chronic renal failure","volume":"22","author":"Diesel","year":"1993","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.clinph.2021.09.012_b0075","first-page":"509","article-title":"Myopathy in chronic renal failure","volume":"43","author":"Floyd","year":"1974","journal-title":"Q J Med"},{"issue":"3","key":"10.1016\/j.clinph.2021.09.012_b0080","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.clinph.2010.06.025","article-title":"Current status on electrodiagnostic standards and guidelines in neuromuscular disorders","volume":"122","author":"Fuglsang-Frederiksen","year":"2011","journal-title":"Clin Neurophysiol"},{"issue":"11","key":"10.1016\/j.clinph.2021.09.012_b0085","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1016\/j.clinph.2020.07.017","article-title":"MScanFit motor unit number estimation and muscle velocity recovery cycle recordings in diabetic polyneuropathy","volume":"131","author":"Kristensen","year":"2020","journal-title":"Clin Neurophysiol"},{"issue":"8","key":"10.1016\/j.clinph.2021.09.012_b0090","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.clinph.2019.04.713","article-title":"MScanFit motor unit number estimation (MScan) and muscle velocity recovery cycle recordings in amyotrophic lateral sclerosis patients","volume":"130","author":"Kristensen","year":"2019","journal-title":"Clin Neurophysiol"},{"issue":"5","key":"10.1016\/j.clinph.2021.09.012_b0095","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0272-6386(05)80030-7","article-title":"Painful myopathy and end-stage renal disease","volume":"37","author":"Kunis","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.clinph.2021.09.012_b0100","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/archneur.1980.00500580051007","article-title":"Proximal muscle weakness in uremia. Case reports and review of the literature","volume":"37","author":"Lazaro","year":"1980","journal-title":"Arch Neurol"},{"issue":"12","key":"10.1016\/j.clinph.2021.09.012_b0105","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.clinph.2019.08.019","article-title":"Sarcolemmal depolarization in sporadic inclusion body myositis assessed with muscle velocity recovery cycles","volume":"130","author":"Lee","year":"2019","journal-title":"Clin Neurophysiol"},{"issue":"3","key":"10.1016\/j.clinph.2021.09.012_b0110","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00421-020-04546-8","article-title":"Regulation of muscle potassium: exercise performance, fatigue and health implications","volume":"121","author":"Lindinger","year":"2021","journal-title":"Eur J Appl Physiol"},{"issue":"8","key":"10.1016\/j.clinph.2021.09.012_b0115","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s11255-020-02508-9","article-title":"Potential mechanisms of uremic muscle wasting and the protective role of the mitochondria-targeted antioxidant Mito-TEMPO","volume":"52","author":"Liu","year":"2020","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"10.1016\/j.clinph.2021.09.012_b0120","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1681\/ASN.2008020159","article-title":"Timing of onset of CKD-related metabolic complications","volume":"20","author":"Moranne","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.clinph.2021.09.012_b0125","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.3390\/nu12061814","article-title":"Uremic Sarcopenia: clinical evidence and basic experimental approach","volume":"12","author":"Nishi","year":"2020","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.clinph.2021.09.012_b0130","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.3390\/ijms20123094","article-title":"Mitochondria as a source and a target for uremic toxins","volume":"20","author":"Popkov","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.clinph.2021.09.012_b0135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/039139888400700501","article-title":"Uremic myopathy","volume":"7","author":"Quintanilla","year":"1984","journal-title":"Int J Artif Organs"},{"issue":"2","key":"10.1016\/j.clinph.2021.09.012_b0140","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/MNH.0000000000000393","article-title":"Chronic kidney disease and acquired mitochondrial myopathy","volume":"27","author":"Rao","year":"2018","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"3","key":"10.1016\/j.clinph.2021.09.012_b0145","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0733-8619(18)30797-7","article-title":"Neurologic manifestations of fluid and electrolyte disturbances","volume":"7","author":"Riggs","year":"1989","journal-title":"Neurol Clin"},{"issue":"1","key":"10.1016\/j.clinph.2021.09.012_b0150","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0733-8619(03)00060-4","article-title":"Neurologic manifestations of electrolyte disturbances","volume":"20","author":"Riggs","year":"2002","journal-title":"Neurol Clin"},{"issue":"4","key":"10.1016\/j.clinph.2021.09.012_b0155","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1152\/physrev.2000.80.4.1411","article-title":"Dynamics and consequences of potassium shifts in skeletal muscle and heart during exercise","volume":"80","author":"Sejersted","year":"2000","journal-title":"Physiol Rev"},{"issue":"37","key":"10.1016\/j.clinph.2021.09.012_b0160","first-page":"1835","article-title":"Neuropathies, myopathies and neuromyopathies in chronic uremic patients","volume":"75","author":"Serratrice","year":"1967","journal-title":"Presse Med"},{"issue":"1","key":"10.1016\/j.clinph.2021.09.012_b0165","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4183\/aeb.2020.95","article-title":"The approach to phytotherapy applications: a case report of hyperkalemia","volume":"16","author":"Sezgin","year":"2020","journal-title":"Acta Endocrinol (Buchar)"},{"issue":"3","key":"10.1016\/j.clinph.2021.09.012_b0170","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.semnephrol.2013.04.009","article-title":"Chronic renal disease progression: treatment strategies and potassium intake","volume":"33","author":"Sinha","year":"2013","journal-title":"Semin Nephrol"},{"issue":"9","key":"10.1016\/j.clinph.2021.09.012_b0175","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.clinph.2019.05.008","article-title":"Standards for quantification of EMG and neurography","volume":"130","author":"St\u00e5lberg","year":"2019","journal-title":"Clin Neurophysiol"},{"issue":"4","key":"10.1016\/j.clinph.2021.09.012_b0180","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.clinph.2019.12.414","article-title":"In vivo assessment of interictal sarcolemmal membrane properties in hypokalaemic and hyperkalaemic periodic paralysis","volume":"131","author":"Tan","year":"2020","journal-title":"Clin Neurophysiol"},{"issue":"2","key":"10.1016\/j.clinph.2021.09.012_b0185","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/mus.25025","article-title":"In vivo assessment of muscle membrane properties in myotonic dystrophy","volume":"54","author":"Tan","year":"2016","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.clinph.2021.09.012_b0190","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/mus.24069","article-title":"Chloride channels in myotonia congenita assessed by velocity recovery cycles","volume":"49","author":"Tan","year":"2014","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.clinph.2021.09.012_b0195","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/mus.25956","article-title":"In vivo assessment of muscle membrane properties in the sodium channel myotonias","volume":"57","author":"Tan","year":"2018","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.clinph.2021.09.012_b0200","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.clinph.2021.01.017","article-title":"Early detection of evolving critical illness myopathy with muscle velocity recovery cycles","volume":"132","author":"Tankisi","year":"2021","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.clinph.2021.09.012_b0205","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cnp.2019.10.005","article-title":"Evidence-based recommendations for examination and diagnostic strategies of polyneuropathy electrodiagnosis","volume":"4","author":"Tankisi","year":"2019","journal-title":"Clin Neurophysiol Pract"},{"issue":"3","key":"10.1016\/j.clinph.2021.09.012_b0210","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/oxfordjournals.ndt.a092434","article-title":"Effect of chronic uraemia on skeletal muscle metabolism in man","volume":"8","author":"Thompson","year":"1993","journal-title":"Nephrol Dial Transplant"},{"issue":"156","key":"10.1016\/j.clinph.2021.09.012_b0215","doi-asserted-by":"crossref","DOI":"10.3791\/60788","article-title":"Muscle velocity recovery cycles to examine muscle membrane properties","author":"Witt","year":"2020","journal-title":"J Vis Exp"},{"issue":"10","key":"10.1016\/j.clinph.2021.09.012_b0220","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.clinph.2020.06.032","article-title":"Detecting peripheral motor nervous system involvement in chronic spinal cord injury using two novel methods: MScanFit MUNE and muscle velocity recovery cycles","volume":"131","author":"Witt","year":"2020","journal-title":"Clin Neurophysiol"},{"issue":"9","key":"10.1016\/j.clinph.2021.09.012_b0225","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.clinph.2019.05.030","article-title":"Muscle velocity recovery cycles in neurogenic muscles","volume":"130","author":"Witt","year":"2019","journal-title":"Clin Neurophysiol"},{"issue":"6","key":"10.1016\/j.clinph.2021.09.012_b0230","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.clinph.2010.01.024","article-title":"Velocity recovery cycles of human muscle action potentials in chronic renal failure","volume":"121","author":"Z\u2019Graggen","year":"2010","journal-title":"Clin Neurophysiol"},{"issue":"5","key":"10.1016\/j.clinph.2021.09.012_b0235","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/mus.21192","article-title":"Velocity recovery cycles of human muscle action potentials and their sensitivity to ischemia","volume":"39","author":"Z'Graggen","year":"2009","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1016\/j.clinph.2021.09.012_b0240","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1016\/j.clinph.2011.04.010","article-title":"Velocity recovery cycles of human muscle action potentials: repeatability and variability","volume":"122","author":"Z'Graggen","year":"2011","journal-title":"Clin Neurophysiol"}],"container-title":["Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245721007458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245721007458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:06:32Z","timestamp":1761393992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388245721007458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1388245721007458"],"URL":"https:\/\/doi.org\/10.1016\/j.clinph.2021.09.012","relation":{},"ISSN":["1388-2457"],"issn-type":[{"value":"1388-2457","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of potassium in muscle membrane dysfunction in end-stage renal disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinph.2021.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Federation of Clinical Neurophysiology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}